Literature DB >> 18818069

2,4(5)-Diarylimidazoles: synthesis and biological evaluation of a new class of sodium channel blockers against hNa(v)1.2.

Mirko Rivara1, Aparna R Baheti, Marco Fantini, Giuseppe Cocconcelli, Chiara Ghiron, Christopher L Kalmar, Natasha Singh, Ellen C Merrick, Manoj K Patel, Valentina Zuliani.   

Abstract

A small family of novel 2,4(5)-diarylimidazoles were prepared through a simple and efficient synthesis and evaluated as potential inhibitors of hNa(v)1.2 sodium channel currents. One member of this series (4) exhibited profound inhibition of Na(v)1.2 currents, emerging as a promising lead compound for further structure-activity relationship studies for the development of novel sodium channel blockers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818069     DOI: 10.1016/j.bmcl.2008.09.036

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Anticonvulsant activity of 2,4(1H)-diarylimidazoles in mice and rats acute seizure models.

Authors:  Valentina Zuliani; Marco Fantini; Aradhya Nigam; James P Stables; Manoj K Patel; Mirko Rivara
Journal:  Bioorg Med Chem       Date:  2010-09-22       Impact factor: 3.641

2.  Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry.

Authors:  Mirko Rivara; Manoj K Patel; Laura Amori; Valentina Zuliani
Journal:  Bioorg Med Chem Lett       Date:  2012-08-23       Impact factor: 2.823

3.  Modular Synthesis of Di- and Trisubstituted Imidazoles from Ketones and Aldehydes: A Route to Kinase Inhibitors.

Authors:  Ian de Toledo; Thiago A Grigolo; James M Bennett; Jonathan M Elkins; Ronaldo A Pilli
Journal:  J Org Chem       Date:  2019-09-30       Impact factor: 4.354

Review 4.  Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers.

Authors:  Mirco Masi; Marco Racchi; Cristina Travelli; Emanuela Corsini; Erica Buoso
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.